Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance
By Justice Department, Drug Enforcement Administration · Nov 5, 2026, 11:00 PM CST
The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although 3-chloromethcathinone is not specifically listed in schedule I of the CSA with its own unique drug code, it is a schedule I
Excerpt shown under fair-use limits. Full text remains with the original publisher.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisFramingThe opening frames the DEA action as a definitive regulatory step, implying authority and finality.
Technical JargonUse of specialized terminology conveys officialdom but may be opaque to lay readers.
Causal ClaimThe article links the scheduling decision directly to chemical similarity without providing supporting evidence or regulatory criteria.
Context
AI analysisMissing context
The article does not provide context about the legal process for adding a substance to Schedule I, the criteria used by the DEA, any public comment period, the potential impact on users or researchers, or health and safety information about 3‑CMC.
Important context
Understanding that Schedule I designation carries significant legal restrictions and that positional isomer rules are part of DEA scheduling policy would help readers assess the significance of the change.
Opinion vs. reporting
AI analysisThe piece presents itself as a factual report of a regulatory action without offering analysis or opinion; however, it makes an unsupported claim about the hallucinogenic status of 4‑chloromethcathinone.